CBDW — 1606 Income Statement
0.000.00%
Last trade - 00:00- $0.25m
- $2.11m
- $0.01m
Annual income statement for 1606, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.068 | 0.034 | 0.014 | 0.002 | 0.007 |
| Cost of Revenue | |||||
| Gross Profit | 0.016 | 0.012 | 0.001 | 0.001 | -0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.296 | 0.335 | 0.554 | 1.62 | 4.11 |
| Operating Profit | -0.228 | -0.301 | -0.54 | -1.62 | -4.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.228 | -0.301 | -0.54 | -1.58 | -4.51 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.228 | -0.301 | -0.54 | -1.58 | -4.51 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.228 | -0.301 | -0.54 | -1.58 | -4.51 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.228 | -0.301 | -0.54 | -1.58 | -4.51 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.006 | -0.007 | -0.009 | -0.032 | -0.058 |